Phaarmasia Limited (PHRMASI.BO)
INR 31.25
(4.94%)
INR 31.25
(4.94%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 50.52 Million INR | -18.42% |
| 2022 | 61.93 Million INR | 27.36% |
| 2021 | 48.63 Million INR | -8.48% |
| 2020 | 53.13 Million INR | -9.11% |
| 2019 | 58.45 Million INR | -34.72% |
| 2018 | 89.54 Million INR | 5.8% |
| 2017 | 84.64 Million INR | 16.12% |
| 2016 | 72.89 Million INR | 0.51% |
| 2015 | 72.52 Million INR | 21.58% |
| 2014 | 59.65 Million INR | 12.69% |
| 2013 | 52.93 Million INR | 34.13% |
| 2012 | 39.46 Million INR | 14.51% |
| 2011 | 34.46 Million INR | 101.51% |
| 2010 | 17.1 Million INR | -31.05% |
| 2009 | 24.8 Million INR | 6.08% |
| 2008 | 23.38 Million INR | -50.38% |
| 2007 | 47.11 Million INR | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q1 | 14.44 Million INR | -8.43% |
| 2023 Q4 | 15.78 Million INR | 51.02% |
| 2023 Q3 | 10.44 Million INR | -43.27% |
| 2023 FY | 50.52 Million INR | -18.42% |
| 2023 Q1 | 15.51 Million INR | 6.39% |
| 2023 Q2 | 18.42 Million INR | 18.7% |
| 2022 Q1 | 14.36 Million INR | 20.22% |
| 2022 FY | 61.93 Million INR | 27.36% |
| 2022 Q4 | 14.58 Million INR | -18.32% |
| 2022 Q3 | 17.85 Million INR | 18.05% |
| 2022 Q2 | 15.12 Million INR | 5.32% |
| 2021 Q3 | 10.33 Million INR | -26.76% |
| 2021 FY | 48.63 Million INR | -8.48% |
| 2021 Q1 | 12.22 Million INR | 20.48% |
| 2021 Q4 | 11.94 Million INR | 15.57% |
| 2021 Q2 | 14.11 Million INR | 15.48% |
| 2020 Q4 | 10.14 Million INR | -30.06% |
| 2020 Q3 | 14.5 Million INR | -5.52% |
| 2020 Q1 | 13.12 Million INR | 7.63% |
| 2020 Q2 | 15.35 Million INR | 16.99% |
| 2020 FY | 53.13 Million INR | -9.11% |
| 2019 FY | 58.45 Million INR | -34.72% |
| 2019 Q1 | 16.07 Million INR | -56.76% |
| 2019 Q2 | 17.45 Million INR | 8.6% |
| 2019 Q3 | 15.02 Million INR | -13.91% |
| 2019 Q4 | 12.19 Million INR | -18.85% |
| 2018 Q2 | 16.68 Million INR | -3.23% |
| 2018 FY | 89.54 Million INR | 5.8% |
| 2018 Q4 | 37.16 Million INR | 101.44% |
| 2018 Q3 | 18.45 Million INR | 10.6% |
| 2018 Q1 | 17.24 Million INR | -12.26% |
| 2017 Q2 | 20.47 Million INR | -36.96% |
| 2017 Q3 | 29.74 Million INR | 45.25% |
| 2017 Q4 | 19.65 Million INR | -33.93% |
| 2017 Q1 | 32.47 Million INR | -9.48% |
| 2017 FY | 84.64 Million INR | 16.12% |
| 2016 FY | 72.89 Million INR | 0.51% |
| 2016 Q3 | 38.08 Million INR | 141.66% |
| 2016 Q2 | 15.75 Million INR | -39.77% |
| 2016 Q4 | 35.88 Million INR | -5.78% |
| 2016 Q1 | 26.16 Million INR | 54.27% |
| 2015 Q2 | 18.14 Million INR | -1.36% |
| 2015 Q3 | 16.62 Million INR | -8.36% |
| 2015 Q4 | 16.96 Million INR | 2.01% |
| 2015 Q1 | 18.39 Million INR | 27.85% |
| 2015 FY | 72.52 Million INR | 21.58% |
| 2014 Q1 | 13.74 Million INR | 58.62% |
| 2014 Q4 | 14.38 Million INR | -1.17% |
| 2014 Q3 | 14.55 Million INR | -6.29% |
| 2014 Q2 | 15.53 Million INR | 13.0% |
| 2014 FY | 59.65 Million INR | 12.69% |
| 2013 Q3 | 15.14 Million INR | -4.33% |
| 2013 Q1 | 13.31 Million INR | 68.08% |
| 2013 FY | 52.93 Million INR | 34.13% |
| 2013 Q2 | 15.83 Million INR | 18.88% |
| 2013 Q4 | 8.66 Million INR | -42.79% |
| 2012 Q2 | 11.33 Million INR | 25.43% |
| 2012 Q4 | 7.92 Million INR | -29.34% |
| 2012 Q3 | 11.21 Million INR | -1.07% |
| 2012 Q1 | 9.03 Million INR | 162.82% |
| 2012 FY | 39.46 Million INR | 14.51% |
| 2011 Q4 | -14.38 Million INR | -219.43% |
| 2011 Q2 | 14.83 Million INR | 0.0% |
| 2011 Q3 | 12.04 Million INR | -18.83% |
| 2011 FY | 34.46 Million INR | 101.51% |
| 2010 FY | 17.1 Million INR | -31.05% |
| 2009 FY | 24.8 Million INR | 6.08% |
| 2008 Q4 | 8.16 Million INR | 0.0% |
| 2008 FY | 23.38 Million INR | -50.38% |
| 2007 FY | 47.11 Million INR | 0.0% |
| 2007 Q4 | 16.83 Million INR | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| Add-Shop E-Retail Limited | 146.52 Million INR | 65.517% |
| Cian Healthcare Limited | 59.19 Million INR | 14.651% |
| Chemo Pharma Laboratories Limited | 1.94 Million INR | -2495.069% |
| Colinz Laboratories Limited | 31.19 Million INR | -61.953% |
| Denis Chem Lab Limited | 453.36 Million INR | 88.855% |
| Emmessar Biotech & Nutrition Limited | 4.32 Million INR | -1069.042% |
| Evoq Remedies Limited | 4.51 Million INR | -1018.574% |
| Gujarat Themis Biosyn Limited | 156.84 Million INR | 67.786% |
| Jenburkt Pharmaceuticals Limited | 437.2 Million INR | 88.443% |
| MedPlus Health Services Limited | 2.42 Billion INR | 97.916% |
| OXYGENTA PHARMACEUTICAL LIMITE | 23.78 Million INR | -112.473% |
| PANJON LTD. | 33.77 Million INR | -49.578% |
| PRAVEG LIMITED | 77.18 Million INR | 34.537% |
| Sanjivani Paranteral Limited. | 208.87 Million INR | 75.811% |
| Sastasundar Ventures Limited | 846.78 Million INR | 94.033% |
| SHAMROCK INDUSTRIAL CO.LTD. | 1.52 Million INR | -3215.354% |
| SHELTER PHARMA LIMITED | 12.3 Million INR | -310.764% |
| BDH Industries Limited | 57.03 Million INR | 11.408% |
| DECIPHER LABS LIMITED | 277.6 Million INR | 81.799% |
| ANG Lifesciences India Limited | 219.92 Million INR | 77.026% |
| Veerhealth Care Limited | 15.38 Million INR | -228.475% |
| Zenith Healthcare Limited | 45.97 Million INR | -9.892% |
| Zenlabs Ethica Limited | 57.89 Million INR | 12.728% |
| Zenotech Laboratories Limited | 94.82 Million INR | 46.715% |
| Crestchem Limited | 50.8 Million INR | 0.544% |
| Norris Medicines Limited | 18.2 Million INR | -177.537% |
| Shukra Pharmaceuticals Limited | 83.05 Million INR | 39.164% |
| Sunil Healthcare Limited | 438.1 Million INR | 88.467% |
| Ambalal Sarabhai Enterprises Limited | 280.83 Million INR | 82.008% |
| Bacil Pharma Limited | 1.87 Million INR | -2595.597% |
| Fredun Pharmaceuticals Limited | 360.45 Million INR | 85.983% |
| Patidar Buildcon Limited | 1.81 Million INR | -2689.95% |
| Shree Ganesh Remedies Limited | 104.13 Million INR | 51.48% |
| SUDARSHAN PHARMA INDUSTRIES LI | 146.09 Million INR | 65.415% |
| Trimurthi Limited | 4.81 Million INR | -950.218% |
| Vista Pharmaceuticals Limited | 20.16 Million INR | -150.55% |
| Vivanza Biosciences Limited | 4.55 Million INR | -1009.243% |
| Hindustan Bio Sciences Limited | 2.6 Million INR | -1837.018% |
| Anuh Pharma Limited | 263.04 Million INR | 80.792% |
| Beryl Drugs Limited | 93.77 Million INR | 46.118% |
| Bharat Immunologicals & Biologicals Corporation Limited | 184.08 Million INR | 72.552% |
| Deccan Health Care Limited | 36.24 Million INR | -39.413% |
| Godavari Drugs Limited | 359.01 Million INR | 85.926% |
| Gujarat Terce Laboratories Limited | 132.41 Million INR | 61.844% |
| Ishita Drugs and Industries Limited | 16.46 Million INR | -206.832% |
| Kerala Ayurveda Limited | 399.64 Million INR | 87.357% |
| KIMIA BIOSCIENCES LIMITED | 149.52 Million INR | 66.208% |
| Lactose (India) Limited | 111.66 Million INR | 54.751% |
| Makers Laboratories Limited | 83.1 Million INR | 39.201% |
| Medi-Caps Limited | 93.11 Million INR | 45.74% |
| Mercury Laboratories Limited | 217.24 Million INR | 76.742% |
| Parmax Pharma Limited | 99.31 Million INR | 49.127% |
| Roopa Industries Limited | 24.63 Million INR | -105.098% |
| Smruthi Organics Limited | 261.73 Million INR | 80.696% |
| Source Natural Foods and Herbal Supplements Limited | 31.85 Million INR | -58.603% |
| Syschem (India) Limited | 64.13 Million INR | 21.216% |
| Vikram Thermo (India) Limited | 104.27 Million INR | 51.546% |
| Bharat Parenterals Limited | 255.97 Million INR | 80.262% |
| Trident Lifeline Limited | 46.87 Million INR | -7.798% |
| Concord Drugs Limited | 91.83 Million INR | 44.98% |
| Gennex Laboratories Limited | 130.37 Million INR | 61.246% |
| TIAAN CONSUMER LIMITED | 107 Thousand INR | -47120.561% |
| Vasundhara Rasayans Limited | 145.5 Million INR | 65.276% |
| Parnax Lab Limited | 80.59 Million INR | 37.306% |
| Trinity League India Limited | -1.08 Million INR | 4752.486% |
| Sandu Pharmaceuticals Limited | 212.9 Million INR | 76.268% |
| Tyche Industries Limited | 182.04 Million INR | 72.245% |
| Kwality Pharmaceuticals Limited | 248.93 Million INR | 79.703% |
| Transchem Limited | 8.47 Million INR | -496.318% |
| Pharmaids Pharmaceuticals Limited | 76.49 Million INR | 33.948% |
| Panchsheel Organics Limited | 68.15 Million INR | 25.87% |
| Coral Laboratories Limited | 189.75 Million INR | 73.374% |
| KOBO BIOTECH LIMITED | 2.48 Million INR | -1937.339% |
| Natural Capsules Limited | 444.7 Million INR | 88.638% |
| Auro Laboratories Limited | 157.37 Million INR | 67.895% |